Tigecycline (Tygacil).
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D008911:Minocycline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity; D012874:Skin Diseases, Infectious / Q000188:drug therapy* / Q000382:microbiology; D000078304:Tigecycline; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000078304:Tigecycline; D008911:Minocycline